Women who breastfeed are advised to wait until nursing is complete before resuming tirzepatide therapy, though some providers may discuss individual timelines based on infant feeding plans
#GLP1 #MetabolicHealth #WeightManagement #Nutraceuticals #BotanicalExtracts #GreenCoffeeBean #ChlorogenicAcid #NaturalAlternatives #ObesityManagement #SupplementScience #DrugDiscontinuation #SustainableWeightLoss #EvidenceBasedNutrition #ProductDevelopment #FormulationScience #PreventiveNutrition #MetabolicSupport #FunctionalIngredients #ClinicalNutrition #PostGLP1 #WeightRegain #NutraceuticalInnovation #PharmaTransition #HerbalMedicine #WellnessScience To view or add a comment, sign in New Clinical on High-Dose Safety Profile for Ashwagandha Root Extract A recent prospective, non-comparative clinical trial published in Frontiers in Nutrition evaluated the safety and tolerability of a standardized Ashwagandha (Withania somnifera) root extract (KSM-66 Ashwagandha) at a high dose of 2,000 mg/day over a 12-week period
It is essential for mitochondrial energy production, DNA repair, and neurotransmitter regulation
TNF-: tumor necrosis factor alpha
As 3 cups of milk are consistent with Dietary Guidelines for Americans (see text footnote 1), our data suggest that older adults can add 1% milk to their daily diet without affecting energy balance
an injection skips the gut entirely and delivers a full, reliable dose
